Logo

GEHC

GE HealthCare Technologies Inc.

GEHC

GE HealthCare Technologies Inc. • NASDAQ
$79.99 ▼ -0.79% (-0.64)
Market Cap $36.54 B
52w High $94.80
52w Low $57.65
Dividend Yield 0.14%
P/E 16.56
Volume 1.05M
Outstanding Shares 456.75M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $5.143B ▲ $1.337B ▲ $446M ▼ 8.672% ▼ $0.98 ▼ $902M ▲
Q2-2025 $5.006B ▲ $1.329B ▼ $486M ▼ 9.708% ▼ $1.06 ▼ $874M ▼
Q1-2025 $4.777B ▼ $1.383B ▼ $564M ▼ 11.807% ▼ $1.23 ▼ $939M ▼
Q4-2024 $5.319B ▲ $1.474B ▲ $720M ▲ 13.536% ▲ $1.58 ▲ $1.085B ▲
Q3-2024 $4.863B $1.349B $471M 9.685% $1.03 $931M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $4.005B ▲ $36.127B ▲ $25.907B ▲ $9.993B ▲
Q2-2025 $3.763B ▲ $35.5B ▲ $25.547B ▲ $9.713B ▲
Q1-2025 $2.473B ▼ $33.586B ▲ $24.168B ▼ $9.188B ▲
Q4-2024 $2.89B ▼ $33.089B ▼ $24.436B ▼ $8.447B ▲
Q3-2024 $3.568B $33.855B $25.345B $8.317B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $464M ▼ $-344M ▼ $-148M ▲ $-165M ▼ $264M ▼ $-454M ▼
Q2-2025 $500M ▼ $94M ▼ $-223M ▲ $1.361B ▲ $1.29B ▲ $8M ▼
Q1-2025 $588M ▼ $250M ▼ $-407M ▼ $-286M ▲ $-417M ▲ $98M ▼
Q4-2024 $738M ▲ $913M ▲ $-240M ▼ $-1.277B ▼ $-679M ▼ $811M ▲
Q3-2024 $489M $738M $-137M $914M $1.554B $648M

Revenue by Products

Product Q3-2024Q4-2024Q1-2025Q2-2025
Imaging Segment
Imaging Segment
 $2.23Bn ▲$1.56Bn ▼$2.14Bn ▲$2.20Bn ▲
PCS Segment
PCS Segment
 $780.00M ▲$830.00M ▲$750.00M ▼$780.00M ▲
PDx Segment
PDx Segment
 $630.00M ▲$650.00M ▲$630.00M ▼$730.00M ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has grown steadily over the past several years, showing a stable, incremental growth profile rather than rapid expansion. Profitability is generally solid: gross profit has improved, and operating earnings have held up well despite industry cost pressures. Earnings dipped after an unusually strong year earlier in the decade that likely reflected one‑off gains, but they have since normalized and are now trending upward again. Overall, the income statement points to a mature, profitable business with moderate growth and relatively resilient margins, rather than a high‑growth, high‑volatility story.

Balance Sheet

Balance Sheet The balance sheet shows a business that has taken on significantly more debt in recent years, likely related to its separation and restructuring activities. Total assets and cash have both increased, which supports day‑to‑day flexibility, but leverage is clearly higher than earlier in the period. Shareholder equity dipped after the restructuring but has started to rebuild, suggesting gradual strengthening of the capital base. In short, the company now operates with a more leveraged but improving balance sheet, where ongoing debt management and balance between growth investments and financial risk are important themes.

Cash Flow

Cash Flow Cash generation is a notable strength. Operating cash flow has been consistently healthy, and free cash flow has remained positive and fairly stable, even through different economic and hospital spending cycles. Capital spending is relatively modest for a large medical technology business, which helps convert a good share of earnings into actual cash. This pattern indicates a business that reliably turns its operations into cash, with enough room to fund investments, service debt, and support other corporate priorities, as long as current conditions persist.

Competitive Edge

Competitive Edge GE HealthCare occupies a leading position in a concentrated global imaging and med‑tech market, competing most directly with a small group of large players. Its advantages come from a powerful brand, a huge installed base of equipment, a deep service and maintenance network, and tight integration of its hardware and software into hospital workflows. These factors make it costly and disruptive for customers to switch providers, reinforcing high switching costs and a durable moat. At the same time, the company still faces intense competition on technology, pricing, and service, and remains exposed to hospital capital budgets and reimbursement trends, which can tighten in weaker economic or policy environments.

Innovation and R&D

Innovation and R&D Innovation is a central pillar of the company’s strategy. It has deep roots in imaging technologies and is now layering advanced digital and AI capabilities across its portfolio. The Edison platform, AI‑enhanced MRI and X‑ray tools, handheld ultrasound with embedded guidance, and upcoming photon‑counting CT systems show a clear push toward faster, more accurate, and more connected diagnostics. The “devices, disease states, and digital” approach aims to embed intelligence into nearly every product and tie them together into a unified ecosystem. The main opportunity is to turn this innovation into better clinical outcomes and stickier customer relationships; the main risks are execution, regulatory approvals, cybersecurity, and keeping pace in a rapidly evolving AI landscape.

Summary

Overall, GE HealthCare combines steady, mature financial performance with a strong competitive position in a concentrated global market and a clear focus on digital and AI‑driven innovation. Earnings and cash flows are stable and robust, though not hyper‑growth, while the balance sheet shows higher leverage than in the past but signs of gradual strengthening. Strategically, the company benefits from high switching costs, a broad and integrated product suite, and a growing digital ecosystem that can deepen customer reliance on its technology. Key uncertainties revolve around managing debt, sustaining innovation leadership against formidable peers, navigating hospital spending cycles, and successfully commercializing its next wave of AI and imaging technologies.

NEWS

November 26, 2025 · 7:59 AM UTC

GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality

Read more

November 25, 2025 · 9:00 AM UTC

GE HealthCare introduces Genesis™ Radiology Workspace: a cloud-first solution with a goal for smarter, faster diagnosis

Read more

November 24, 2025 · 5:15 PM UTC

GE HealthCare announces cash dividend for fourth quarter of 2025

Read more

November 24, 2025 · 8:12 AM UTC

GE HealthCare's Photonova™ Spectra with Deep Silicon reimagines photon-counting CT to see more, know more and achieve more

Read more

November 20, 2025 · 4:05 PM UTC

GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings

Read more